Biotech

All Articles

IN 8bio halts period 2 test, lays off half of staff

.Only a couple of months after application the very first individual in a period 2 trial for newly d...

Lilly, Haya ink $1B biobuck obesity deal to browse dark genome

.Eli Lilly's look for excessive weight aim ats has actually led it to the darker genome. The Big Pha...

ArsenalBio elevates $325M, pivots off of former lead asset

.Collection Biosciences is moving on up. The cell treatment provider has actually added on $325 mill...

Lilly- backed weight management biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' marijuana use medicine fails stage 2b, driving Indivior to reconsider $100M option

.Aelis Farma's chances of safeguarding a fast, good selection on a $one hundred million possibility ...

ProKidney stops stage 3 test certainly not required for cell treatment authorization

.ProKidney has ceased some of a set of phase 3 trials for its cell therapy for kidney condition afte...

Vaxcyte surges on 'remarkable' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what experts referred to as "spectacular" stage 1/2 records for its 31-valent pneu...

Recursion's mind ailment test presents insufficient evidence of efficacy

.Recursion has discovered by means of an early test of its own tech-enabled technique to drug discov...

Acepodia, Pfizer click together for chemistry-based tissue therapy

.Phone it a situation of excellent chemistry: Acepodia, a biotech based upon Nobel Champion scientif...

Praxis epilepsy medicine decreases confiscations in stage 2 litigation

.Praxis Preciseness Medicines has actually scored one more midphase succeed in epilepsy this year, w...